Abstract
As a serious public health problem worldwide, suicide and related behaviors have merited a large body of research investigating their underlying biology. A number of studies suggest that a genetic component that is partly independent from the familial transmission of major psychiatric disorders may be involved in these behaviors. The serotoninergic system has been the neurotransmitter system most closely associated with the neurobiology of suicidal behavior. In particular, a number of studies have focused on the serotonin-2C (5-HT2C) receptor in relation to suicidality. Studies involving mRNA editing as well as postmortem studies on brain tissues of patients with schizophrenia and major depression have shown promise in this area. Site-specific changes in the editing of the mRNA HTR2C and different 5-HT2C receptor isoforms have been found in association with completed suicide.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anisman H, Du L, Palkovits M (2008) Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects. J Psychiatry Neurosci 33:131–141.
Arango V, Mann JJ (1992) Relevance of serotonergic postmortem studies to suicidal behaviour. Int Rev Psychiatry 4:131–140.
Arango V, Underwood MD (1997) Serotonin chemistry in the brain of suicide victims. In: Mans R, Silverman M, Canetto S, eds. Review of Suicidology. New York: Guilford Press.
Asberg M, Traskman L, Thoren P (1976) 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor? Arch Gen Psychiatry 33:1193–1197.
Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083–1152.
Baxter LR Jr., Clark EC, Ackermann RF, et al (2001) Brain mediation of Anolis social dominance displays. II. Differential forebrain serotonin turnover, and effects of specific 5-HT receptor agonists. Brain Behav Evol 57:184–201.
Brent DA, Oquendo M, Birmaher B, et al (2002) Familial pathways to early-onset suicide attempt: Risk for suicidal behaviour in offspring of mood-disordered suicide attempters. Arch Gen Psychiatry 59:801–807.
Burns CM, Chu H, Rueter SM, et al (1997) Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387:303–308.
Burris KD, Breeding M, Sanders-Bush E (1991) (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist. J Pharmacol Exp Ther 258:891–896.
Canton H, Verriele L, Colpaert FC (1990) Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: Clozapine potently interacts with 5-HT1C sites. Eur J Pharmacol 191:93–96.
Canton H, Emeson RB, Barker EL, et al (1996) Identification, molecular cloning, and distribution of a short variant of the 5–hydroxytryptamine2C receptor produced by alternative splicing. Mol Pharmacol 50:799–807.
Chen K, Yang W, Grimsby J, et al (1992) The human 5-HT2 receptor is encoded by a multiple intron-exon gene. Mol Brain Res 14:20–26.
Cooper SJ, Kelly CB, King DJ (1992) 5-Hydroxyindoleacetic acid in cerebrospinal fluid and prediction of suicidal behaviour in schizophrenia. Lancet 340:940–941.
De Luca V, Tharmaligam S, Strauss J, et al (2008) 5-HT2C receptor and MAO-A interaction analysis: No association with suicidal behaviour in bipolar patients. Eur Arch Psychiatry Clin Neurosci 258:428–433.
Dracheva S, Patel N, Woo DA, et al (2008a) Increased serotonin 2C receptor mRNA editing: A possible risk factor for suicide. Mol Psychiatry 13:1001–1010.
Dracheva S, Chin B, Haroutunian V (2008b) Altered serotonin 2C receptor RNA splicing in suicide: association with editing. Neuroreport 19:379–382.
Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116–1127.
Ebstein RP, Segman R, Benjamin J, et al (1997) 5-HT2C (HTR2C) serotonin receptor gene polymorphism associated with the human personality trait of reward dependence. Interaction with dopamine D4 receptor (D4DR) and dopamine D3 receptor (D3DR) polymorphisms. Am J Med Genet 74:65–72.
Egan C, Herrick-Davis K, Teitler M (1998) Creation of a constitutively activated state of the 5-HT2A receptor by site-directed mutagenesis: revelation of inverse agonist activity of antagonists. Ann N Y Acad Sci 861:136–139.
Fitzgerald LW, Iyer G, Conklin DS, et al (1999) Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology 21(2 Suppl):82S–90S.
Garfinkel BD, Froese A, Hood J (1982) Suicide attempts in children and adolescents. Am J Psychiatry 139:1257–1261.
Gershon ES (1990) Genetics. In: Goodwin FK, Jamison KR (eds). Maniac Depressive Illness. New York: Oxford University Press.
Gurevich I, Tamir H, Arango V, et al (2002) Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 34:349–356.
Holmes C, Arranz MJ, Powell JF, et al (1998) 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer’s disease. Hum Mol Genet 7:1507–1509.
Jenck F, Moreau JL, Mutel V, et al (1993) Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs. Eur J Pharmacol 231:223–229.
Julius D, MacDermott AB, Axel R, et al (1988) Molecular characterization of a functional cDNA encoding the serotonin 1c receptor. Science 241:558–564.
Julius D, Huang KN, Livelli TJ, et al (1990) The 5HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors. Proc Natl Acad Sci USA 87:928–932.
Kaufman MJ, Hartig PR, Hoffman BJ (1995) Serotonin 5-HT2C receptor stimulates cyclic GMP formation in choroid plexus. J Neurochem 64:199–205.
Kennett GA, Wood MD, Bright F, et al (1997) SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36:609–620.
Kõks S, Nikopensius T, Koido K, et al (2006) Analysis of SNP profiles in patients with major depressive disorder. Int J Neuropsychopharmacol 9:167–174.
Lappalainen J, Zhang L, Dean M, et al (1995) Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C). Genomics 27:274–279.
Lester D (1995) The concentration of neurotransmitter metabolites in the cerebrospinal fluid of suicidal individuals: a meta-analysis. Pharmacopsychiatry 28:45–50.
Li D, He L (2007) Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behaviour. Mol Psychiatry 12:47–54.
Lübbert H, Hoffman BJ, Snutch TP, et al (1987) cDNA cloning of a serotonin 5-HT1C receptor by electrophysiological assays of mRNA-injected Xenopus oocytes. Proc Natl Acad Sci USA 84:4332–4336.
Mann JJ (2003) Neurobiology of suicidal behaviour. Nat Rev Neurosci 4:819–828.
Mann JJ, Arango V, Marzuk PM, et al (1989) Evidence for the 5-HT hypothesis of suicide. A review of post-mortem studies. Br J Psychiatry Suppl (8):7–14.
Mann JJ, Malone KM, Nielsen DA, et al (1997) Possible association of a polymorphism of the tryptophan hydroxytase gene with suicidal behaviour in depressed patients. Am J Psychiatry 154:1451–1453.
Mann JJ, Waternaux C, Haas GL, et al (1999) Towards a clinical model of suicidal behaviour in psychiatric patients. Am J Psychiatry 156:181–189.
Mann JJ, Huang Y, Underwood MD, et al (2000) A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57:729–738.
Martin P, Waters N, Schmidt CJ, et al (1998) Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone. J Neural Transm 105:365–396.
Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3:e442.
Mathers CD, Bernard C, Iburg KM, et al (2003) Global burden of disease in 2002: Data sources, methods and results. Paper presented at the Global Programme on Evidence for Health Policy. Geneva, Switzerland, World Health Organization.
Moreau JL, Bös M, Jenck F, et al (1996) 5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats. Eur Neuropsychopharmacol 6:169–175.
Murray CL, Lopez AD, eds. (1996) The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, MA, Harvard University Press.
Ninan PT, van Kammen DP, Scheinin M, et al (1984) CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients. Am J Psychiatry 141:566–569.
Niswender CM, Copeland SC, Herrick-Davis K, et al (1999) RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem 274:9472–9478.
Niswender CM, Herrick-Davis K, Dilley GE, et al (2001) RNA editing of the human serotonin HTR2C. Alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 24:478–491.
Oquendo MA, Currier D, Mann JJ (2006) Prospective studies of suicidal behaviour in major depressive and bipolar disorders: what is the evidence for predictive risk factors? Acta Psychiatr Scand 114:151–158.
Oquendo MA, Baca-García E, Mann JJ, et al (2008) Issues for DSM-V: Suicidal behaviour as a separate diagnosis on a separate axis. Am J Psychiatry 165:1383–1384.
Pandey GN (1997) Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies. Ann N Y Acad Sci 836:182–200.
Pfeffer CR, Normandin L, Kakuma T (1994) Suicidal children grow up: Suicidal behaviour and psychiatric disorders among relatives. J Am Acad Child Adolesc Psychiatry 33:1087–1097.
Pfennig A, Kunzel HE, Kern N, et al (2005) Hypothalamus-pituitary-adrenal system regulation and suicidal behaviour in depression. Biol Psychiatry 57:336–342.
Pooley EC, Houston K, Hawton K, et al (2003) Deliberate self-harm is associated with allelic variation in the tryptophan hydroxylase gene (TPH A779C), but not with polymorphisms in five other serotonergic genes. Psychol Med 33:775–783.
Posner K, Oquendo MA, Gould M, et al (2007) Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA’s pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 164:1035–1043.
Robins E, Guze SB (1970) Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry 126:983–987.
Roth BL, Ciaranello RD (1991) Chronic mianserin treatment decreases 5-HT2 receptor binding without altering 5-HT2 receptor mRNA levels. Eur J Pharmacol 207:169–172.
Roy A (1993) Genetic and biologic risk factors for suicide in depressive disorders. Psychiatric Q 64:345–358.
Roy A, Segal NL, Sarchiapone M (1995) Attempted suicide among living co twins of twin suicide victims. Am J Psychiatry 152:1075–1076.
Roy A, Rytander G, Sarchiapone M (1997) Genetics of suicide: Family studies and molecular genetics. Ann N Y Acad Sci 836:135–157.
Segman RH, Ebstein RP, Heresco-Levy U, et al (1997) Schizophrenia, chronic hospitalization and the 5-HT2C receptor gene. Psychiatr Genet 7:75–78.
Serretti A, Mandelli L, Giegling I, et al (2007) HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers. Am J Med Genet B Neuropsychiatr Genet 144:291–299.
Serretti A, Calati R, Giegling I, et al (2009) Serotonin receptor HTR1A and HTR2C variants and personality traits in suicide attempters and controls J Psychiatr Res 43:519–525.
Stam NJ, Vanhuizen F, Vanalebeek C, et al (1992) Genomic organization, coding sequence and functional expression of human 5-HT2 and 5-HT1A receptor genes. Eur J Pharmacol 227:153–162.
Statham DJ, Heath AC, Madden PAF, et al (1998) Suicidal behaviour: an epidemiological and genetic study. Psychol Med 28:839–855.
Stefulj J, Buttner A, Kubat M, et al (2004) 5HT-2C receptor polymorphism in suicide victims. Association studies in German and Slavic populations. Eur Arch Psychiatry Clin Neurosci 254:224–227.
Strohle A, Holsboer F (2003) Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry 36:207–214.
U.S. Department of Health and Human Services (2000) With understanding and improving health and objectives for improving health, 2 vols. Healthy People 2010. 2nd.ed. Washington, DC: U.S. Department of Health and Human Services.
U.S. Public Health Service (1999) The Surgeon General’s call to action to prevent suicide. Washington, DC: U.S. Public Health Service.
Vollenweider FX, Leenders KL, Scharfetter C, et al (1997) Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology 16:357–372.
Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, et al (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9:3897–3902.
Voracek M, Loibl LM (2007) Genetics of suicide: a systematic review of twin studies. Wien Klin Wochenschr 119:463–475.
Westrin A (2000) Stress system alterations and mood disorders in suicidal patients. A review. Biomed Pharmacother 54:142–145.
World Health Organization (1996) Prevention of suicide: guidelines for the formulation and implementation of national strategies. Geneva, World Health Organization.
Xie E, Zhao L, Levine AJ, et al (1996) Human serotonin 5-HT2C receptor gene: Complete cDNA, genomic structure, and alternatively spliced variant. EMBL accession number U49516.
Yu L, Nguyen H, Le H, et al (1991) The mouse 5-HT1C receptor contains eight hydrophobic domains and is X-linked. Mol Brain Res 11:143–149.
Acknowledgments
Dr. De Luca has been supported by a NARSAD Young Investigator Award and an American Foundation for Suicide Prevention Pilot Grant.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Panariello, F., Javaid, N., De Luca, V. (2011). 5-HT2C Receptors and Suicidal Behavior. In: Di Giovanni, G., Esposito, E., Di Matteo, V. (eds) 5-HT2C Receptors in the Pathophysiology of CNS Disease. The Receptors, vol 22. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-941-3_13
Download citation
DOI: https://doi.org/10.1007/978-1-60761-941-3_13
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-940-6
Online ISBN: 978-1-60761-941-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)